Community-acquired Chlamydia pneumoniae pneumonia in Japan: A prospective multicenter community-acquired pneumonia study

Internal Medicine

Volumn 41, Issue 11, 2002, Pages 943-949

  Miyashita, Naoyuki ^g   Saito, Atsushi ^a   Kohno, Shigeru ^b   Oizumi, Kotaro ^c   Yamaguchi, Keizo ^d   Watanabe, Akira ^e   Oda, Hiroshi ^f   Fukano, Hiroshi ^g   Yoshida, Koichiro ^g   Niki, Yoshihito ^g   Matsushima, Toshiharu ^g  

^a UNIVERSITY OF THE RYUKYUS   (Japan)

^b NAGASAKI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c KURUME UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d TOHO UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e TOHO UNIVERSITY   (Japan)

^f KAGOSHIMA UNIVERSITY   (Japan)

^g KAWASAKI MEDICAL SCHOOL   (Japan)

Author keywords

Atypical pneumonia; Bacterial pneumonia; CAP guideline; Clinical feature; Concomitant infection

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ARTIFICIAL VENTILATION; BACTERIAL PNEUMONIA; BACTERIUM ISOLATION; CELL CULTURE; CHLAMYDOPHILA PNEUMONIAE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FEVER; HUMAN; IMMUNOFLUORESCENCE TEST; INTENSIVE CARE UNIT; JAPAN; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; POLYMERASE CHAIN REACTION; PRACTICE GUIDELINE; PROSPECTIVE STUDY; PULSE RATE; SERODIAGNOSIS; BACTERIAL INFECTION; CLINICAL TRIAL; COMMUNICABLE DISEASE; HEALTH SURVEY; MIDDLE AGED;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CHLAMYDOPHILA INFECTIONS; CHLAMYDOPHILA PNEUMONIAE; COMMUNITY-ACQUIRED INFECTIONS; FEMALE; HUMANS; JAPAN; MALE; MIDDLE AGED; PNEUMONIA, BACTERIAL; POPULATION SURVEILLANCE; PROSPECTIVE STUDIES;

EID: 0036857523     PISSN: 09182918     EISSN: None     Source Type: Journal    
DOI: 10.2169/internalmedicine.41.943     Document Type: Article

References (34)

1. Grayston JT, Campbell LA, Kuo CC, et al. A new respiratory tract pathogen: Chlamydia pneumoniae strain TWAR. J Infect Dis 161: 618-625, 1990.
2. Kuo CC, Jackson LA, Campbell LA, Grayston JT. Chlamydia pneumoniae (TWAR). Clin Microbiol Rev 8: 451-461, 1995.
3. Miyashita N, Kubota Y, Nakajima M, Niki Y, Kawane H, Matsushima T. Chlamydia pneumoniae and exacerbations of asthma in adults. Ann Allergy Asthma Immunol 80: 405-409, 1998.
4. Miyashita N, Niki Y, Nakajima M, Kawane H, Matsushima T. Chlamydia pneumoniae infection in patients with diffuse panbronchiolitis and COPD. Chest 114: 969-971, 1998.
5. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. Seroepidemiology of Chlamydia pneumoniae in Japan between 1991 and 2000. J Clin Pathol 55: 115-117, 2002.
6. Boman J, Hammerschlag MR. Chlamydia pneumoniae and atherosclerosis: Critical assessment of diagnostic methods and relevance to treatment studies. Clin Microbiol Rev 15: 1-20, 2002.
7. Miyashita N, Toyota E, Sawayama T, Matsushima T. An association of an antibody against Chlamydia pneumoniae and coronary heart disease observed in Japan [letter]. Eur Heart J 19: 971, 1998.
8. Miyashita N, Toyota E, Sawayama T, et al. Association of chronic infection of Chlamydia pneumoniae and coronary heart disease in the Japanese. Intern Med 37: 913-916, 1998.
9. Hammerschlag MR. Chlamydia pneumoniae and the lung. Eur Respir J 16: 1001-1007, 2000.
10. Ishida T, Hashimoto T, Arita M, Ito I, Osawa M. Etiology of community-acquired pneumonia in hospitalized patients: a 3-year prospective study in Japan. Chest 114: 1588-1593, 1998.
11. Miyashita N, Fukano H, Niki Y, Matsushima T, Okimoto N. Etiology of community-acquired pneumonia requiring hospitalization in Japan. Chest 119: 1295-1296, 2001.
12. Saito A, Kohno S, Matsushima T, et al and For the Study Group. Prospective multicenter study on the causative organisms of community-acquired pneumonia in adults in Japan (submitting for publication).
13. Miyashita N, Matsumoto A, Soejima R, et al. Evaluation of a direct fluorescent antibody assay for detection of Chlamydia pneumoniae. Jpn J Assoc Infect Dis (Kansenshogaku Zasshi) 70: 224-231, 1996.
14. Miyashita N, Niki Y, Nakajima M, Fukano H, Matsushima T. Prevalence of asymptomatic infection with Chlamydia pneumoniae in subjectively healthy adults. Chest 119: 1416-1419, 2001.
15. Miyashita N, Kubota Y, Kimura M, et al. Characterization of Chlamydia pneumoniae strain isolated from a 57-year-old man. Microbiol Immunol 38: 857-864, 1994.
16. The Japanese Respiratory Society, Community-acquired pneumonia Treatment Guideline Creation Committee. Practice guideline for the management of community-acquired pneumonia in adults. in: Matsushima T, Kohno S, Saito A, Nakata K, Yamaguchi K, Watanabe A, Eds. The Japanese Respiratory Society (Tokyo) 2000 (in Japanese).
17. Miyashita N, Fukano H, Okimoto N, et al. Clinical presentation of community-acquired Chlamydia pneumoniae pneumonia in adults. Chest 121: 1776-1781, 2002.
18. Miyashita N, Niki Y, Kishimoto T, Nakajima M, Matsushima T. In vitro and in vivo activities of AM-1155, a new fluoroquinolone, against Chlamydia spp. Antimicrob Agents Chemother 41: 1331-1334, 1997.
19. Miyashita N, Niki Y, Matsushima T. In vitro and in vivo activities of sitafloxacin against Chlamydia spp. Antimicrob Agents Chemother 45: 3270-3272, 2001.
20. Miyashita N, Fukano H, Niki Y, Matsushima T. In vitro activity of telithromycin, a new ketolide, against Chlamydia pneumoniae. J Antimicrob Chemother 48: 403-405, 2001.
21. Miyashita N, Fukano H, Yoshida K, Niki Y, Matsushima T. In vitro activity of moxifloxacin and other fluoroquinolones against Chlamydia species. J Infect Chemother 8: 115-117, 2002.
22. Marrie TJ, Grayston JT, Wang SP, Kuo CC. Pneumonia associated with the TWAR strain of Chlamydia. Ann Intern Med 106: 507-511, 1987.
23. Fang GD, Fine M, Orloff J, et al. New and emerging etiologies for community-acquired pneumonia with implications for therapy. A prospective multicenter study of 359 cases. Medicine 69: 307-316, 1990.
24. Blasi F, Cosentini R, Legnani D, Denti F, Allegra L. Incidence of community-acquired pneumonia caused by Chlamydia pneumoniae in Italian patients. Eur J Clin Microbiol Infect Dis 12: 696-699, 1993.
25. Sundelof B, Gnarpe J, Gnarpe H, Grillner L, Darougar S. Chlamydia pneumoniae in Swedish patients. Scand J Infect Dis 25: 429-433, 1993.
26. Kauppinen MT, Saikku P, Kujala P, Herva E, Syrjala H. Clinical picture of community-acquired Chlamydia pneumoniae pneumonia requiring hospital treatment: a comparison between chlamydial and pneumococcal pneumonia. Thorax 51: 185-189, 1996.
27. Lieberman D, Ben-Yaakov M, Lazarovich Z, et al. Chlamydia pneumoniae community-acquired pneumonia: A review of 62 hospitalized adult patients. Infection 24: 109-114, 1996.
28. Steinhoff D, Lode H, Ruckdeschel G, et al. Chlamydia pneumoniae as a cause of community-acquired pneumonia in hospitalized patients in Berlin. Clin Infect Dis 22: 958-964, 1996.
29. Suttithawil W, Wangroongasrb P, Naigowit P, Nunthapisud P, Chantadisai N, Ploysongsang Y. Chlamydophila (Chlamydia) pneumoniae as a cause of community-acquired pneumonia in Thailand. J Med Assoc Thai 84: 430-437, 2001.
30. Gaydos CA, Roblin PM, Hammerschlag MR, et al. Diagnostic utility of PCR-enzyme immunoassay, culture, and serology for detection of Chlamydia pneumoniae in symptomatic and asymptomatic patients. J Clin Microbiol 32: 903-905, 1994.
31. Hyman CL, Roblin PM, Gaydos CA, Quinn TC, Schachter J, Hammerschlag MR. Prevalence of asymptomatic nasopharyngeal carriage of Chlamydia pneumoniae in subjectively healthy adults: Assessment by polymerase chain reaction-enzyme immunoassay and culture. Clin Infect Dis 20: 1174-1178, 1995.
32. Kern DG, Neill MA, Schachter J. A seroepidemiologic study of Chlamydia pneumoniae in Rhode island. Evidence of serologic cross-reactivity [see comments]. Chest 104: 208-213, 1993.
33. Dowell SF, Peeling RW, Boman J, et al. Standardizing Chlamydia pneumoniae assays: Recommendations from the Centers for Disease Control and Prevention (USA) and the Laboratory Centre for Disease Control (Canada). Clin Infect Dis 33: 492-503, 2001.
34. Shemer-Avni Y, Liberman D. Chlamydia pneumoniae-induced ciliostasis in ciliated bronchial epithelial cells. J Infect Dis 171: 1274-1278, 1995.